Olema Pharmaceuticals Inc.
Olema Pharmaceuticals is a San Francisco‑based clinical‑stage biopharma developing palazestrant—an ER antagonist/degrader—in Phase 3 for ER+/HER2‑ metastatic breast cancer, plus other oncology candidates.
Headquarters: United States (USA)
- Website: Visit Site 🔗
- Type: Corporation
Company Profile
- Sector: Professional Services
- Industry: Biotechnology Research
- Employees: 122
- HQ: San Francisco
Unlock the full potential.
Upgrade
Get access to Relative P/E Ratio Valuation Histogram.